Author: Danielle Pillsbury
CERTAINTY – Japan
Location (City): Shinagawa, Tokyo Venue: TKP Garden City PREMIUM Shinagawa Takanawa GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to Certara experts, industry leaders and your peers with an opportunity hear the latest innovations and opportunities to achieve better certainty in drug development. Register now to be the first to know new details of … Continued
CERTAINTY – China
Location (City): in Shanghai Venue: Crowne Plaza Shanghai Jinxiu GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to Certara experts, industry leaders and your peers with an opportunity hear the latest innovations and opportunities to achieve better certainty in drug development. Register now to be the first to know new details of the event … Continued
CERTAINTY – South Korea
Location (City): in PangyoVenue: GRAVITY SEOUL PANGYO GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to Certara experts, industry leaders and your peers with an opportunity hear the latest innovations and opportunities to achieve better certainty in drug development. Register now to be the first to know new details of the event as we … Continued
RAPS Sponsored Webcast: Regulatory & Tech Advances in Drug Safety Reporting
Meeting the escalating global demand for new medications requires expediting regulatory submission development. Documenting drug safety issues occurring in clinical research is a major aspect of regulatory and medical writing. Two major types of safety regulatory documents are the development safety update report (DSUR) and the patient safety narrative. This webcast will discuss the latest … Continued
Drug developers need curated clinical outcomes data to inform critical decisions
Conducting Clinical Trials in the Parallel Virtual Universe
AI Enabling Biosimulation: Innovating the Path of Drug Research and Development
Location: Suzhou Adock Innovation Center (1F Multi-function Lecture Hall, Adock Innovation Center, No. 328 Xinghu Street, Suzhou Industrial Park, Suzhou, China) Overview: With the rapid development of technology, AI technology has penetrated all aspects of our lives. In the field of drug research and development, the combination of AI and biosimulation has brought revolutionary changes … Continued
The Neuroplatform: Towards a Comprehensive Mechanistic QSP Model of Alzheimer’s Disease for Supporting Drug Discovery and Development
With over 55 million people diagnosed worldwide, Alzheimer’s disease presents a significant public health challenge, with treatment costs and caregiver burden reaching staggering figures, expected to exceed a trillion dollars soon. Explore the latest insights into Alzheimer’s disease and drug development in Dr. Hugo Geerts’ presentation at the University of Indiana. Learn about the development … Continued
Explore the World of Endogenous Biomarkers with Simcyp™!
Endogenous biomarkers play a pivotal role in comprehending drug-body interactions, shaping drug development, and propelling precision medicine forward. With our latest software release, the Simcyp™ Simulator introduces innovative features tailored to endogenous biomarkers. In a comprehensive overview led by our expert presenter, Dr. Matthew Harwood, Principal Scientist in Translational DMPK, shares insights into: Dr. Harwood … Continued
